(Q54342441)

28 May 2018

title

Clinical relevance of molecular aberrations in paediatric acute myeloid leukaemia at first relapse. (English)

1 reference

28 May 2018

Marry M van den Heuvel-Eibrink

1 reference

7

object named as

Marry M van den Heuvel-Eibrink

1 reference

28 May 2018

author name string

Costa Bachas

1

1 reference

28 May 2018

Gerrit Jan Schuurhuis

2

1 reference

28 May 2018

Dirk Reinhardt

3

1 reference

28 May 2018

Ursula Creutzig

4

1 reference

28 May 2018

Zinia J Kwidama

5

1 reference

28 May 2018

C Michel Zwaan

6

1 reference

28 May 2018

Evelina S J M De Bont

8

1 reference

28 May 2018

Sarah Elitzur

9

1 reference

28 May 2018

Carmelo Rizzari

10

1 reference

28 May 2018

Valérie de Haas

11

1 reference

28 May 2018

Martin Zimmermann

12

1 reference

28 May 2018

Jacqueline Cloos

13

1 reference

28 May 2018

Gertjan J L Kaspers

14

1 reference

28 May 2018

language of work or name

English

0 references

publication date

25 June 2014

1 reference

28 May 2018

British Journal of Haematology

published in

1 reference

28 May 2018

volume

166

1 reference

28 May 2018

issue

6

1 reference

28 May 2018

page(s)

902-910

1 reference

28 May 2018

Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia.

cites work

1 reference

Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia

21 January 2018

1 reference

Molecularly targeted therapies for pediatric acute myeloid leukemia: progress to date

21 January 2018

1 reference

Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel

21 January 2018

1 reference

Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?

21 January 2018

1 reference

Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12.

21 January 2018

1 reference

Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group

21 January 2018

1 reference

Pediatric acute myeloid leukemia

21 January 2018

1 reference

How I treat paediatric relapsed acute myeloid leukaemia

21 January 2018

1 reference

Pediatric acute myeloid leukemia: towards high-quality cure of all patients

21 January 2018

1 reference

Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group

21 January 2018

1 reference

FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model

21 January 2018

1 reference

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

21 January 2018

1 reference

Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia

21 January 2018

1 reference

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.

21 January 2018

1 reference

Biology, risk stratification, and therapy of pediatric acute leukemias: an update

21 January 2018

1 reference

Cooperating gene mutations in acute myeloid leukemia: a review of the literature.

21 January 2018

1 reference

Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials

21 January 2018

1 reference

ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome

21 January 2018

1 reference

Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia

21 January 2018

1 reference

Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy.

21 January 2018

1 reference

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

21 January 2018

1 reference

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 January 2018

1 reference

Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.

21 January 2018

1 reference

Management of relapsed acute myeloid leukaemia

21 January 2018

1 reference

Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.12989

1 reference

28 May 2018

1 reference

28 May 2018